On April, 4th, 2017, Shareholder Congress of Hai Duong Pharmaceutical Medical Material JSC (HDPHARMA) took place and ended with success.
On April, 4th, 2017, annual shareholder congress of 2017 was successfully organized by HDPHARMA. At the congress, many important reports, papers was approved such as Report on production and sale of 2016, and Financial budget in 2017; Report of Administrative Council, Report on activities of Controlling Board, etc
With the attendance of 223 shareholders and the authorized people, all items of the Congress agenda was discussed as planned.
At the conference, the participants voted and passed these following items:
– Approval of Report of Administrative Council, Controlling Board, Report on Business and Sales in 2016 of BOD
– Appoval of audited financial report in 2016
– Approval of Plan of profit distribution and diviend payment in 2016
– Approval of Profit Plan and Financial Budget in 2017
– Approval of Report of salary for the members of Administrative Council, Controlling Board in 2016 and the payment plan for 2017
– Agreement of the suggestion to authorize Administrative Council to choose an independent company to make the financial audit in 2017
– Approval of the amendment of the Charter
– Approval of adjusting investment on the production lines of the Plant in Cam Thương
All these above contents were approved by the Congress participants
Annual Shareholder Congress in 2017 of HDPHARMA came to a successful ending with the consent from all the shareholders.